Simple Summary Triple-negative breast cancer (TNBC) is a highly aggressive subtype of
breast cancer that cannot be treated with endocrine therapy and Her2-targeted therapy …

Abstract Small Nucleolar RNAs (snoRNAs) are known for their canonical functions, including
ribosome biogenesis and RNA modification. snoRNAs act as endogenous sponges that …

Here we report for the first time the relation between breast cancer subtypes and 10‐year
recurrence rates and mortality in the Netherlands. All operated women diagnosed with …

Objective: Triple-negative breast cancer (TNBC) involves higher rates of recurrence and
distant metastasis. The present study sought to characterize the risk factors for distant …

Purpose To evaluate the pattern of recurrence of breast cancer according to its biological
subtype in a large cohort of patients treated with therapy representative of current practice …

Breast cancer (BC) epidemic in the twenty-first century is characterised by around half a
million deaths and 1.7 million new cases registered annually worldwide. Metastatic disease …

Approximately 30% of breast cancer survivors deemed free of disease will experience
locoregional or metastatic recurrence even up to 30 years after initial diagnosis, yet how …

Background Breast cancer in African women differs from the Caucasian. Understanding the
profile of Nigerian women with breast cancer will help with preventive measures and …

Introduction Triple negative breast cancer (TNBC) is a rare but aggressive biological
subtype of breast cancer associated with higher locoregional and distant recurrence rates …

Globally, approximately 1 in 4 cancers in women are diagnosed as breast cancer (BC).
Despite significant advances in the diagnosis and therapy BCs, many patients develop …